ClinicalTrials.Veeva

Menu

Pediatric ACL: Understanding Treatment Options (PLUTO)

Boston Children's Hospital logo

Boston Children's Hospital

Status

Active, not recruiting

Conditions

Anterior Cruciate Ligament Reconstruction

Treatments

Procedure: Surgical technique: Partial transphyseal reconstruction
Procedure: Surgical technique: Physeal sparing reconstruction by the Micheli/Kocher method
Procedure: Surgical technique: Physeal sparing reconstruction by the Anderson method
Other: Non-operative treatment group will undergo standardized treatment which will include rehabilitation, bracing and certain activity restrictions
Procedure: Surgical technique: Transphyseal reconstruction

Study type

Observational

Funder types

Other

Identifiers

NCT02772770
IRB-P00017850

Details and patient eligibility

About

Pediatric ACL: Understanding Treatment Outcomes (PLUTO) is a multi-center, prospective cohort study. Specific aims of PLUTO are to evaluate the safety and comparative effectiveness of non-operative treatment, as well as four operative treatments including (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique in prepubescent and pubescent skeletally immature patients.

Full description

Anterior Cruciate Ligament (ACL) injuries are being seen with increased frequency in pediatric and adolescent patients. The management of these injuries is controversial and includes nonoperative treatment and operative treatment with various surgical techniques. Pediatric ACL: Understanding Treatment Outcomes (PLUTO) is a multi-center, prospective cohort study. Specific aims of PLUTO are to evaluate the safety and comparative effectiveness of non-operative treatment, as well as four operative treatments including (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique in prepubescent and pubescent skeletally immature patients. Accrual will take place over eight years at 9 pediatric sports medicine centers. Post-treatment outcome assessment will be performed at 6-9 months, 1 year, and 2, 5, and 10 years after treatment , including functional outcome, activity level, health-related quality of life, graft survivorship, knee stability, knee motion, and growth disturbance.

Enrollment

765 patients

Sex

All

Ages

5 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosis of complete intrasubstance ACL tear
  • Skeletally Immature (by knee radiographs)

Exclusion criteria

  • Prior ACL surgery on the ipsilateral knee
  • Congenital ACL deficiency
  • Multiple ligament reconstruction required
  • Other significant comorbidities including syndromic conditions, neuromuscular disorders or developmental delay
  • If scheduling of the ACL surgery is impacted by the skeletal maturity of the patient
  • Simultaneous bilateral ACL tears

Trial design

765 participants in 5 patient groups

Non Operative: Rehabilitation, Bracing, Activity Restriction
Treatment:
Other: Non-operative treatment group will undergo standardized treatment which will include rehabilitation, bracing and certain activity restrictions
Operative: Transphyseal
Treatment:
Procedure: Surgical technique: Transphyseal reconstruction
Operative: Partial Transphyseal
Treatment:
Procedure: Surgical technique: Partial transphyseal reconstruction
Operative: Physeal sparing by Anderson Technique
Treatment:
Procedure: Surgical technique: Physeal sparing reconstruction by the Anderson method
Operative: Physeal sparing by Micheli/Kocher Technique
Treatment:
Procedure: Surgical technique: Physeal sparing reconstruction by the Micheli/Kocher method

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems